At the PCC, we recognize that applying for grants is a time consuming and arduous process. Despite this, not all applications are fruitful. As the premier anti-doping research collaborative, the PCC has assessed hundreds of grant applications and noticed commonalities [...]
This is an opinion piece by Jenna Celmer, Stakeholder Engagement Manager for the PCC. Why is the Partnership for Clean Competition a global leader in anti-doping research? I could go on for days, but one of the biggest reasons is we [...]
The anti-doping movement is constantly evolving to mitigate prohibited performance-enhancing activities and ensure the protection of clean athletes. At times, opinions on the direction anti-doping administrators should pursue vacillate wildly, making for a complex and challenging global conundrum. The PCC, however, [...]
Dr. Thevis, (PhD, GTFCh), the anti-doping scientist and professor from Germany, speaks with the PCC about his Mildronate study, choosing the anti-doping discipline, and what's next on his radar. What got you started in anti-doping research? I was a third year chemistry student [...]
A seminar at the University of Utah by Dr. Daniel Eichner, president of the Sports Medicine Research and Testing Laboratory (SMRTL) piqued Dr. Geoff Miller's interest back in 2014. Now, he's on track for a promising career in anti-doping research. With [...]
We are excited to present to you our first newsletter: your opportunity to explore a sampling of the achievements, perspectives and scientific projects of our researchers, while keeping informed of funding deadlines and programs. We hope you enjoy and encourage you [...]
We are excited to present to you our first newsletter: your opportunity to explore a sampling of the achievements, perspectives and scientific projects of our researchers, while keeping informed of funding deadlines and programs. We hope you enjoy and encourage you [...]
Please click on the below cover to view the PCC's 2014 Annual Report (PDF)
What a Drop Can Do: Dried blood spot sampling (DBS) is a form of bio-sampling that has been used for decades to screen patients for diseases that can be identified via metabolic markers – such as congenital metabolic diseases in infants. [...]
